| |
|
|
|
Wellcome Trust, Hinxton, Cambridge
14/01/2015
The Wellcome Trust, in association with the UK Pharmacogenomics and Stratified Medicine Network, is pleased to announce the third Pharmacogenetics and Stratified Medicine meeting. This meeting will once again bring together leaders from academia, regulatory bodies, healthcare organisations, pharmaceutical and diagnostics industries, to discuss recent progress in this area. This year’s meeting will focus on the UK environment for stratified medicine and will review current public and regulatory perceptions. It will also highlight developments in clinical trial design and advances in key areas of research; including Pharmacogenomics, rare diseases, rheumatoid arthritis, and cancer. We encourage multidisciplinary participation in the conference as it provides a forum for discussion, new ideas and collaborations. To facilitate a highly interactive conference, the number of places available will be limited to 150 participants, therefore early registration is recommended. Please visit the website for further information: https://registration.hinxton.wellcome.ac.uk/display_info.asp?id=466
|
|
|
|
|
|
|
|
Organized by:
|
|
Wellcome Trust Scientific Conferences |
|
|
Invited Speakers:
|
|
Anne Barton The University of Manchester,UK
Tim Cox University of Cambridge, UK
Ann Daly Newcastle University, UK
Gordon Duff Medicines and Healthcare Products Regulatory Agency, UK
Mathew Garnett Wellcome Trust Sanger Institute, UK
Alasdair Gaw Innovate, UK
Tim Hubbard King's College London, UK
Tim Maughan University of Oxford, UK
Jonathan Pearce Medical Research Council, UK
Tony Soteriou Department of Health, UK
Joyce Tait University of Edinburgh, UK
Ian Walker CR-UK
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
No abstracts
|
|
|
|
|
|
|
|
Registration:
|
|
Registration deadline: 1st December 2014
|
|
|
E-mail:
|
|
scientificconferences@hinxton.wellcome.ac.uk
|
|
|
|
|
|
|
|
|